XYXili Yang

Xili Yang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xili Yang has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Jiayi Zhu

    Department of Cardiology, The First People’s Hospital of Foshan, No. 81 Lingnan RD, Foshan 528000, PR China

    2 shared publications
  • Cuiying Mo

    Department of Endocrinology, The First People’s Hospital of Foshan, Foshan, Guangdong 528000, China

    1 shared publication
  • Feng Qiu

    Department of Laboratory Medicine, The Seventh Affiliated Hospital of Southern Medical University, Foshan, Guangdong 528244, China

    1 shared publication
  • Guoqiang Chen

    Department of Rheumatology, First People's Hospital of Foshan, China; Department of Rheumatology, Second People's Hospital of Foshan, China

    1 shared publication
  • Huiting Tan

    Department of Endocrinology, The First People’s Hospital of Foshan, 528000 Foshan, Guangdong, China

    1 shared publication
  • Jianyu Zhang

    Department of Cardiology, The First People’s Hospital of Foshan, No. 81 Lingnan RD, Foshan 528000, PR China

    1 shared publication

Latest Publications

  • Open Access

    Unique intestinal microflora and metabolic profile in different stages of hypertension reveal potential biomarkers for early diagnosis and prognosis

    by Yaren Yu, Jiayi Zhu, Ruixue Fu, Lina Guo, Tao Chen, Zhaoyan Xu, Jianyu Zhang, Wensheng Chen, Lushi Chen, Xili Yang

    Introduction. Hypertension is the most prevalent chronic disease and a major risk factor for cardiovascular and cerebrovascular diseases. Gap statement. However, there has been no substantial breakthrough in aetiology, new drug targets, and drug development of hypertension in recent 50 years. Research aim. Therefore, this study was to screen unique intestinal microbiome and serum metabolic biomarkers which can early diagnose and track the prognosis of hypertension patients in different periods, and analyse its underlying mechanisms and functions. Methods. Four groups of stool and serum samples, including healthy controls (HCs), prehypertension (PHT), hypertension (HT), and hypertension-related complications (HTC), were collected. Microbial diversity assessed using 16S rRNA sequencing. The metabolites in serum samples were detected through LC-MS/MS analysis. Results. The composition of gut microbiota in patients exhibited dissimilarities compared to that in healthy subjects, which was distinguished by Prevotella, Slackia, Enterococcus, Bifidobacterium, and Lactobacillales may be potential markers for tracking the progression of hypertension, and Bifidobacterium, Butyricimonas, Adlercreutzia, Faecalibacterium, Lactobacillus, Ruminococcus, Clostridium, and Acidaminococcus demonstrated diagnostic value. Meanwhile, tracking the dynamic changes of deoxycholic acid, 4-oxododecanedioic acid, and l-arginine can serve as biomarkers for early diagnosis, and investigation into the mechanism by which the intestinal microbiome influences the onset and progression of hypertension. In terms of pathogenesis, the findings revealed that Bifidobacterium may caused the changes of AST, indirect bilirubin, ALT, triglyceride and uric acid by affecting metabolites cis-7-hexadecenoic acid methyl ester and N1-acetylspermidine. Additionally, Coprococcus may cause changes in albumin through the influence of androsterone enanthate. Conclusions. These findings highlight that the unique intestinal microbiome and serum metabolic profile in different periods of hypertension will provide valuable insight for timely diagnosis and prognosis tracking in hypertension patients with promising clinical applications.


  • Open Access

    Cyclometalated Ir(III) Complexes as Lysosome-Targeted Photodynamic Anticancer Agents

    by Jiayi Zhu, Yan Liu, Zhao Zhang, Xili Yang, Feng Qiu

    We have designed and synthesized two Ir(III) complexes (Ir1 and Ir2) coordinated with an 8-sulfonamidoquinoline derivative ligand as photosensitizers, which exhibit strong red phosphorescence emission and a long phosphorescence lifetime. The Ir(III) complexes exhibit a high population of triplet states, which enable red phosphorescence and efficient singlet oxygen generation. Ir1 and Ir2 rapidly enter the cancer cells and accumulate in lysosomes, producing large amounts of intracellular singlet oxygen when exposed to light irradiation, eventually leading to cancer cell death, and the phototoxic indexes of complexes Ir1 and Ir2 against cancer cells are in the range of 76-228. Overall, our studies indicate that the synthesized Ir(III) complexes with quinoline ligands exhibit photosensitizing properties, effectively inducing cancer cell death when exposed to light. These promising results suggest their potential application in photodynamic therapy.


  • Retracted
    Open Access

    [Retracted] Exploring the Temporal Correlation of Sarcopenia with Bone Mineral Density and the Effects of Osteoblast‐Derived Exosomes on Myoblasts through an Oxidative Stress–Related Gene

    by Jingsong Chen, Jie Shen, Xili Yang, Huiting Tan, Ronghua Yang, Cuiying Mo, Ying Wang, Xiaojun Luan, Wenhua Huang, Guoqiang Chen, et al.

    Sarcopenia is an age‐related accelerated loss of muscle strength and mass. Bone and muscle are closely related as they are physically adjacent, and bone can influence muscle. However, the temporal association between bone mineral density (BMD) and muscle mass in different regions of the body after adjustment for potential indicators and the mechanisms by which bone influences muscle in sarcopenia remain unclear. Therefore, this study aimed to explore the temporal association between muscle mass and BMD in different regions of the body and mechanisms by which bone regulates muscle in sarcopenia. Here, cross‐lagged models were utilized to analyze the temporal association between BMD and muscle mass. We found that low‐density lipoprotein (LDL‐C) positively predicted appendicular lean mass. Mean whole‐body BMD (WBTOT BMD), lumbar spine BMD (LS BMD), and pelvic BMD (PELV BMD) temporally and positively predicted appendicular lean mass, and appendicular lean mass temporally and positively predicted WBTOT BMD, LS BMD, and PELV BMD. Moreover, this study revealed that primary mice femur osteoblasts, but not primary mice skull osteoblasts, induced differentiation of C2C12 myoblasts through exosomes. Furthermore, the level of long noncoding RNA (lncRNA) taurine upregulated 1 (TUG1) was decreased, and the level of lncRNA differentiation antagonizing nonprotein coding RNA (DANCR) was increased in skull osteoblast–derived exosomes, the opposite of femur osteoblast–secreted exosomes. In addition, lncRNA TUG1 enhanced and lncRNA DANCR suppressed the differentiation of myoblasts through regulating the transcription of oxidative stress–related myogenin (Myog) gene by modifying the binding of myogenic factor 5 (Myf5) to the Myog gene promoter via affecting the nuclear translocation of Myf5. The results of the present study may provide novel diagnostic biomarkers and therapeutic targets for sarcopenia.